Dr. Jan Bruder

Max-Planck Institute for Molecular Biomedicine

Dr. Jan Bruder Explores How Automation Has Advanced Understanding of Neurodegenerative Diseases

Dr. Jan Bruder, Max-Planck Institute for Molecular Biomedicine, discusses his work combining stem cells with automation to drive towards drug development for neurodegenerative diseases such as Parkinson’s and Motor Neuron Disease. In this presentation Dr. Bruder looks at the system requirements for drug screening and how they are crucial for better understanding of these increasingly common diseases.

LIKE 1


Dr. Jan Bruder
Health Sciences Screening

Dr. Jan Bruder

Biography

Dr. Jan Bruder is postdoctoral associate at Max-Planck Institute for Molecular Biomedicine. More
Follow Jan

Dr. Jan Bruder

Max-Planck Institute for Molecular Biomedicine

Dr. Bruder's interest focus on translating basic stem cell-based techniques and protocols into workflows that are suitable for high-throughput-screening applications. He thus bridges the gap between basic stem cell science and translational approaches. His areas of expertise include human stem cells, automation, assay design, neurodegenerative disease modeling, and 3D cell culture.